This Article Full Text Full Text (PDF) All Versions of this Article: 37/2/518    most recent 01.STR.0000198835.49387.25v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Seker, A. Articles by Gunel, M. Search for Related Content PubMed PubMed Citation Articles by Seker, A. Articles by Gunel, M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Protein UniGene Genetics Home Reference Related Collections Genetics of Stroke Other Stroke Other Vascular biology

(Stroke. 2006;37:518.)
© 2006 American Heart Association, Inc.

Original Contributions

CCM2 Expression Parallels That of CCM1

Askin Seker, MD; Katie L. Pricola, BA; Bulent Guclu, MD; Ali K. Ozturk, BA; Angeliki Louvi, PhD Murat Gunel, MD

From the Yale Neurovascular Surgery Program, Department of Neurosurgery, Yale University School of Medicine, New Haven, Conn.

Correspondence to Murat Gunel, MD, Department of Neurosurgery, Yale University School of Medicine, 333 Cedar St, New Haven, CT 06510. E-mail murat.gunel{at}yale.edu

Background and Purpose— Mutations in CCM2 (MGC4607 or malcavernin) cause familial cerebral cavernous malformation (CCM), an autosomal dominant neurovascular disease. Both the function of this molecule and the pathogenesis of the disease remain elusive.

Methods— We analyzed the mRNA expression of Ccm1 and Ccm2 in the embryonic and postnatal mouse brain by in situ hybridization. Subsequently, we generated CCM2-specific polyclonal antibodies and tested their specificity using transient transfection experiments in various cell lines. We then investigated CCM2 protein expression in cerebral and extracerebral tissues by Western blot analysis as well as immunohistochemistry and compared these results with CCM1 (KRIT1) protein expression.

Results— In situ analysis shows similar temporal and spatial expression patterns for Ccm1 and Ccm2, although Ccm1 expression appears more widespread. Immunohistochemical analysis shows that CCM2 is expressed in various human organs, most noticeably in the arterial vascular endothelium. As is the case with CCM1, CCM2 is not expressed in other vascular wall elements such as smooth muscle cells or the venous circulation. Within cerebral tissue, it is also expressed in pyramidal neurons, astrocytes, and their foot processes. In extracerebral tissues, CCM2 is present in various epithelial cells necessary for blood-organ barrier formation.

Conclusions— CCM1 and CCM2 have similar expression patterns during development and postnatally thereafter. Given the fact that the disease phenotypes caused by mutations in either gene are clinically and pathologically indistinguishable, the significant overlap in expression pattern supports the hypothesis that both molecules are involved in the same pathway important for central nervous system vascular development.

Key Words: cavernous malformations

This article has been cited by other articles:

				D. Mariappan, R. Niemann, M. Gajewski, J. Winkler, S. Chen, S. Choorapoikayil, M. Bitzer, H. Schulz, J. Hescheler, and A. Sachinidis Somitovasculin, a Novel Endothelial-Specific Transcript Involved in the Vasculature Development Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1823 - 1829. [Abstract] [Full Text] [PDF]

				L. Chen, G. Tanriover, H. Yano, R. Friedlander, A. Louvi, and M. Gunel Apoptotic Functions of PDCD10/CCM3, the Gene Mutated in Cerebral Cavernous Malformation 3 Stroke, April 1, 2009; 40(4): 1474 - 1481. [Abstract] [Full Text] [PDF]

				B. M. Hogan, J. Bussmann, H. Wolburg, and S. Schulte-Merker ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish Hum. Mol. Genet., August 15, 2008; 17(16): 2424 - 2432. [Abstract] [Full Text] [PDF]

				P. Brouillard and M. Vikkula Genetic causes of vascular malformations Hum. Mol. Genet., October 15, 2007; 16(R2): R140 - R149. [Abstract] [Full Text] [PDF]

				N Revencu and M Vikkula Cerebral cavernous malformation: new molecular and clinical insights J. Med. Genet., September 1, 2006; 43(9): 716 - 721. [Abstract] [Full Text] [PDF]